Healthcare Poland banner: a rising polyline with five waypoint nodes and the caption “Polska – Izrael” on a warm light background, symbolising an orderly patient route from the treating physician to a reference centre.

An orderly patient route. What Healthcare Poland is doing in Israel for patients from Poland

Posted by:

|

On:

|

Poland–Israel cooperation · Access to treatment

For several months the Healthcare Poland Foundation has been building one thing with partners in Israel: an orderly route for patients from Poland to consultations, diagnostics and therapies that are not yet available in our system, or become available with a delay that in oncology can be decisive.

The premise: delay is a clinical parameter

In public debate, the time it takes to reach treatment is usually treated as an organisational inconvenience — a queue, a date, a procedure. In diseases with fast dynamics it is something else. There, time is a clinical variable: the difference between a therapy available now and the same therapy available in nine months is not a difference of comfort but a difference of prognosis. We take this as the premise that orders all of our work.

An institutional consequence follows. If an option exists beyond Poland’s borders that a treating physician would want to use for their patient, then the absence of an orderly route to that option is a problem of the system, not a private difficulty of the family. A family translating discharge summaries at midnight and hunting for the e-mail address of a foreign clinic is doing work an institution should have done.

This is not medical tourism

Medical tourism is a commercial relationship between a patient and a foreign provider. What we are building is something different: informational and organisational infrastructure around the decision of the treating physician. The entry point to the route is a doctor — not an advertisement and not a search engine.

In practice this means that a physician in Poland — when they judge that their patient could benefit from options available in Israel — knows whom to call, which documents are required, how long it takes, what it costs and who is responsible for what. The patient does not buy hope from us. Their physician obtains a complete set of information on which a decision can be taken — or deliberately not taken.

Three pillars of the work

Framework with Sheba

Sheba Medical Center is among the world’s leading clinical centres. Under the arrangement being designed, Sheba’s International Division receives patients while the Foundation organises documentation, communication and logistics on the Polish side. The framework remains under discussion — we will announce when it is finalised.

Navigation service for physicians

Intake from the treating physician, a completeness check of the records, arranging consultation at a reference centre, translation, preparation of documents for the applicable access procedures, and coordination of subsequent steps between the Israeli centre and the physician in Poland.

Mapping access conditions

Therapies already registered outside the European Union but not yet in Poland: who may apply, on what legal basis, through which authorised channel and at what cost. We do this with pharmaceutical and legal partners so that what we tell a patient is still true three months later.

How the route runs

The enquiry route in five steps From left to right: step 01, the treating physician submits a clinical question; step 02, completeness check of the medical records; step 03, consultation at a reference centre; step 04, preparation of documents for the applicable access procedure, including targeted import; step 05, the decision is handed back to the treating physician in Poland. 01Treatingphysiciansubmits a clinicalquestion02Recordscompletenesscheck03Consultationat a referencecentre04Accessproceduredocuments, incl.targeted import05Decisionhanded back tothe physician
Five steps from a physician’s question to a decision. The application in an access procedure is filed by an authorised entity, not by the Foundation.
  1. Intake from the treating physician. The route begins with the doctor who knows the patient and carries responsibility for the course of treatment. The enquiry carries a clinical question, not a general request for help.
  2. Completeness check of the records. We verify whether the documentation allows a foreign centre to issue an opinion. Gaps are identified before any cost is triggered.
  3. Consultation at a reference centre. We arrange the consultation, the translations and the flow of documents. The content of the opinion belongs to the centre; we are answerable for it arriving complete and in time.
  4. The regulatory path. If the consultation indicates a therapy unavailable in Poland, we prepare documents for the applicable access procedure — including targeted import where the statutory conditions are met. The application is filed by an authorised entity, not by the Foundation.
  5. Cost and timeline on the table. Patient and physician learn the real cost and the real timeline before the decision is taken, not after it. If the route is unrealistic, we say so plainly.
  6. Return to the treating physician. Every variant ends with the complete set of information handed back to the doctor in Poland. It is they who continue to lead the patient — including when the answer is “no”.
Who decides what Three roles. The treating physician takes the medical decision: indication, eligibility and the conduct of treatment. The competent authorities take the regulatory decision: consent to the access procedure, including targeted import. The Healthcare Poland Foundation is responsible for organisation and information: records, translation, coordination, cost and timing. The boundary of the role: the Foundation does not qualify patients for treatment and does not import medicinal products. Treating physicianMedical decision: indication,eligibility and the conductof treatment.Competent authoritiesRegulatory decision: consent tothe access procedure, includingtargeted import.Healthcare PolandOrganisation and information:records, translation,coordination, cost and timing. The boundary: the Foundation does not qualify patients for treatment and does not import medicinal products.
Three decisions, three responsibilities. The Foundation’s role ends where the clinical or the regulatory decision begins.

The limits of our role, stated plainly

  • We do not qualify patients for treatment and we do not issue medical opinions.
  • We do not buy, import or resell medicinal products.
  • We do not promise supply, reimbursement or funding of any therapy.
  • We do not advertise medicinal products to the general public.

The medical decision belongs to the physician and the regulatory decision to the competent authorities. Our role is to make those decisions possible sooner and on complete information. This is why the Foundation’s remuneration for navigation work is a flat fee, independent of the price of any medicinal product — a condition without which the separation between organisational help and commercial interest cannot be maintained.

Records and data protection

Medical records are not correspondence. Please do not send them via LinkedIn, messaging applications or ordinary e-mail. Once an enquiry is received we indicate a secured channel for transferring data and the scope that is genuinely required — health data belongs to the special categories of personal data and we process it only to the extent necessary to perform the task the physician has asked for.

Who this invitation is addressed to

Physicians

If you are treating a patient for whom you are considering options available in Israel, write to us. We will answer a specific question specifically — and if the answer is “this will not work”, we will say so at once.

Patients and families

Speak to your treating physician and ask them to contact us. This is not a formality: without a doctor the route has neither a point of departure nor a point of arrival.

Partners

Centres, pharmaceutical entities, law firms and patient organisations willing to co-build this route on the Polish or the Israeli side are invited to discuss the scope and terms of cooperation.

Enquiries: access to therapy and cooperation

This form is addressed to treating physicians, to families acting in agreement with their physician, and to institutions interested in cooperation. Please do not send medical records through this channel — once we receive your enquiry we will indicate a secure route for transferring data.

* indicates required
We will answer your enquiry at this address.
The route begins with the treating physician — this determines how we respond.

Please select how we may respond to this enquiry:

You can withdraw this consent at any time by clicking the link in the footer of our emails. For information about our data practices, please visit the Foundation’s website.

We use Mailchimp as our marketing platform. By submitting this form, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices.

Alternatively: global@healthcarepoland.pl. Please mark the subject line “Israel — physician enquiry” or “Israel — cooperation”.

This material is informational. It is not medical advice, not advertising of a medicinal product and not an offer within the meaning of the Polish Civil Code. The Healthcare Poland Foundation does not trade in medicinal products and takes no part in qualifying patients for treatment. Cooperation with Israeli centres remains under discussion; its finalisation will be announced separately.

Healthcare Poland Logo